SCHEMBL22556979

SCHEMBL22556979

CC(C)(C)OC1CCN(NC=O)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9675535 0.89 — —
SCHEMBL27801025 0.81 — —
SCHEMBL17106593 0.80 — —
SCHEMBL26105401 0.71 CARM1 (0.34) —
SCHEMBL4569268 0.69 TP53 (0.46) —
SCHEMBL1106464 0.69 HRH3 (0.37) —
SCHEMBL3893979 0.67 GPR119 (0.34) —
SCHEMBL17625290 0.67 — —
SCHEMBL9611082 0.67 ATM (0.32) —
SCHEMBL22959617 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020211822-A1 A CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DEGRADATION OF ANDROGEN RECEPTORS AND USE THEREOF 成都海创药业有限公司 2020-10-22 — — WO disclosed
Send feedback